Christopher Pierce

Christopher Pierce

Keine laufenden Positionen mehr

44 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Christopher Pierce

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 26
Subsidiary Pharmaceuticals: Major 12
Public Company Biotechnology 6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Christopher Pierce

UnternehmenSektorVerknüpfte PersonenHauptposition
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Ronald Shazer

Corporate Officer/Principal

Biotechnology

Lori Kunkel

Martin Babler

Corporate Officer/Principal

Sales & Marketing

INCYTE CORPORATION Pharmaceuticals: Major

Julian Baker

Director/Board Member

JOHNSON & JOHNSON Pharmaceuticals: Major

Alan Mendelsohn

Amrit Ray

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

ELI LILLY AND COMPANY Pharmaceuticals: Major

Josh Bilenker

Martin Babler

Corporate Officer/Principal

Corporate Officer/Principal

XOMA CORPORATION Pharmaceuticals: Major

Kelvin Neu

Lori Kunkel

Director/Board Member

Corporate Officer/Principal

EXELIXIS, INC. Pharmaceuticals: Major

Ronald Shazer

Richard Buller

Corporate Officer/Principal

Corporate Officer/Principal

ESPERION THERAPEUTICS, INC. Pharmaceuticals: Major

Alan Fuhrman

Tim Mayleben

Director/Board Member

Director of Finance/CFO

Investment Managers

Julian Baker

Kelvin Neu

Founder

Portfolio Manager-Equities

AMBIT BIOSCIENCES CORP Pharmaceuticals: Major

Alan Fuhrman

David Bonita

Steven Elms

Director of Finance/CFO

Director/Board Member

Director/Board Member

LENSAR, INC. Medical Specialties

Steven Elms

Josh Bilenker

Chairman

Director/Board Member

University of Notre Dame College/University

Stacey T. Eisen

Timothy Sullivan

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

David Bonita

Josh Bilenker

Director/Board Member

Director/Board Member

Investment Managers

Steven Elms

Josh Bilenker

Private Equity Investor

Private Equity Investor

TRACON PHARMACEUTICALS, INC. Pharmaceuticals: Major

Ronald Shazer

Chief Tech/Sci/R&D Officer

REBUS HOLDINGS, INC. Biotechnology

Ronald Shazer

Richard Buller

Chief Tech/Sci/R&D Officer

Director/Board Member

ULTRAGENYX PHARMACEUTICAL INC. Pharmaceuticals: Major

Mardi Dier

Amrit Ray

Director of Finance/CFO

Director/Board Member

VIEWRAY, INC. Medical Specialties

David Bonita

Josh Bilenker

Director/Board Member

Director/Board Member

College/University

Julian Baker

David Bonita

Undergraduate Degree

Undergraduate Degree

Stanford University College/University

Steven Elms

Mardi Dier

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

John Paolini

Corporate Officer/Principal

College/University

Lori Kunkel

Kimberly Ma

Doctorate Degree

Undergraduate Degree

Investment Managers

Julian Baker

Private Equity Investor

Tulane University (Louisiana) College/University

John Paolini

Undergraduate Degree

Princeton University College/University

Josh Bilenker

Kelvin Neu

Undergraduate Degree

Undergraduate Degree

University of California San Diego College/University

Lori Kunkel

Ronald Shazer

Undergraduate Degree

Undergraduate Degree

New York Medical College College/University

Ronald Shazer

Doctorate Degree

Hospital/Nursing Management

John Paolini

Corporate Officer/Principal

General Government

Josh Bilenker

Maritza McIntyre

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Julian Baker

Kelvin Neu

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

John Paolini

Chief Tech/Sci/R&D Officer

Harvard Medical School College/University

Kelvin Neu

Keith Flaherty

Ole Isacson

Ottavio V. Vitolo

Devyn Smith

Doctorate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Graduate Degree

Doctorate Degree

Pharmaceuticals: Major

Anthony Maddaluna

Kirsten Lund Jurgensen

President

President

National Comprehensive Cancer Network Foundation

Josh Bilenker

Deborah Morosini

Director/Board Member

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Lara Sullivan

Jeff Lotz

Masters Business Admin

Graduate Degree

Kellogg School of Management College/University

Tim Mayleben

Steven Elms

Masters Business Admin

Masters Business Admin

UCLA Anderson School of Management College/University

Mardi Dier

Ronald Shazer

Masters Business Admin

Masters Business Admin

The Johns Hopkins University School of Medicine College/University

Steven Harr

Josh Bilenker

Keith Flaherty

Doctorate Degree

Doctorate Degree

Doctorate Degree

Duke University School of Medicine College/University

John Paolini

Doctorate Degree

CHECKMATE PHARMACEUTICALS, INC. Biotechnology

Alan Fuhrman

Keith Flaherty

Chief Executive Officer

Director/Board Member

ORIC PHARMACEUTICALS, INC. Pharmaceuticals: Major

Mardi Dier

Lori Kunkel

Director/Board Member

Director/Board Member

KINIKSA PHARMACEUTICALS, LTD. Pharmaceuticals: Major

John Paolini

Chief Tech/Sci/R&D Officer

MADRIGAL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Julian Baker

Mardi Dier

Chairman

Director of Finance/CFO

Biotechnology

Alan Fuhrman

Lara Sullivan

Director/Board Member

Founder

SANA BIOTECHNOLOGY, INC. Biotechnology

Steven Harr

Josh Bilenker

Founder

Director/Board Member

Miscellaneous Commercial Services

Steven Harr

Torben Nissen

Director/Board Member

Chief Executive Officer

Biotechnology

David Bonita

Avi Z. Naider

Steven Elms

Josh Bilenker

Jennifer Burstein

Director/Board Member

Director/Board Member

Director/Board Member

Founder

Corporate Officer/Principal

Pharmaceuticals: Major

Julian Baker

Martin Babler

Director/Board Member

Chief Executive Officer

Statistik

International

Vereinigte Staaten 50
Irland 2

Sektoral

Health Technology 28
Consumer Services 16
Finance 4
Commercial Services 3
Health Services 2

Operativ

Director/Board Member 209
Corporate Officer/Principal 114
Independent Dir/Board Member 84
Undergraduate Degree 35
Chief Tech/Sci/R&D Officer 28
  1. Börse
  2. Insiders
  3. Christopher Pierce
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT